Redmile Group, LLC, Director, 10% Owner at IGM Biosciences, Inc. (IGMS), bought 289,612 shares at $52.96 ($14.6M) on 2020-09-09, disclosed to the SEC on 2020-09-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.28 | 74,433 | $3.7M | 25.6% |
| 2 | $50.28 | 74,433 | $3.7M | 25.6% |
| 3 | $49.91 | 47,113 | $2.4M | 16.1% |
| 4 | $49.91 | 47,113 | $2.4M | 16.1% |
| 5 | $51.85 | 8,650 | $449K | 3.1% |
| 6 | $51.85 | 8,650 |
| $449K |
| 3.1% |
| 7 | $52.96 | 14,610 | $774K | 5.3% |
| 8 | $52.96 | 14,610 | $774K | 5.3% |
| Total | $50.52 avg | 289,612 | $14.6M | 100% |
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |